The key for optimizing cell-line development for antibody derivatives might just be to prioritize early assessment of product ...

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...

Industrial cell line development needs mammalian cell lines derived from one progenitor cell. Therefore, regulatory agencies ask to evaluate the probability of clonality (PoC) to ensure safe ...